Cargando…
Pharmacokinetics and safety of the two oral cefaclor formulations in healthy chinese subjects in the fasting and postprandial states
We conducted a phase I bioequivalence trial in healthy Chinese subjects in the fasting and postprandial states. The goal of this trial was to compare the pharmacokinetics and safety of the test preparation Cefaclor granule (Disha Pharmaceutical Group Co., Ltd.) and the reference preparation Cefaclor...
Autores principales: | Qu, Xinyao, Deng, Qiaohuan, Li, Ying, Li, Peng, Liu, Guangwen, Wang, Yanli, Liu, Zhengzhi, Yu, Shuang, Cheng, Yang, Zhou, Yannan, Chen, Jiahui, Ren, Qing, Yu, Zishu, Su, Zhengjie, Zhao, Yicheng, Yang, Haimiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9581244/ https://www.ncbi.nlm.nih.gov/pubmed/36278160 http://dx.doi.org/10.3389/fphar.2022.1012294 |
Ejemplares similares
-
Pharmacokinetics and bioequivalence of sunitinib and Sutent(®) in Chinese healthy subjects: an open-label, randomized, crossover study
por: Wang, Yanli, et al.
Publicado: (2023) -
Pharmacokinetics, Immunogenicity and Safety Study for SHR-1309 Injection and Perjeta® in Healthy Chinese Male Volunteers
por: Cui, Yingzi, et al.
Publicado: (2021) -
Corrigendum: Pharmacokinetics, Immunogenicity and Safety Study for SHR-1309 Injection and Perjeta(®) in Healthy Chinese Male Volunteers
por: Cui, Yingzi, et al.
Publicado: (2022) -
Population Pharmacokinetic Analysis of Cefaclor in Healthy Korean Subjects
por: Jeong, Seung-Hyun, et al.
Publicado: (2021) -
Proper Cut-off Levels of Serum Specific IgE to Cefaclor for Patients with Cefaclor Allergy
por: Nam, Young-Hee, et al.
Publicado: (2018)